Sign Up to like & get
recommendations!
0
Published in 2021 at "Organic letters"
DOI: 10.1021/acs.orglett.1c02770
Abstract: The poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib is used in the clinic to treat BRCA-mutated cancers. Herein, we report two strategies to access the 18F-isotopologue of rucaparib by applying a copper-mediated nucleophilic 18F-fluorodeboronation. The most successful…
read more here.
Keywords:
copper mediated;
mediated radiosynthesis;
rucaparib;
18f rucaparib ... See more keywords